Salt Composition
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Used In
Treatment of Status epilepticus / Treatment of Short term anxiety / Treatment of Anxiety disorder
Customers also bought
More About Psypose 2mg Injection 2ml
Benefits
In Treatment of Status epilepticus : Status epilepticus is when a seizure lasts longer than 5 minutes or when seizures occur close together and the person doesn't recover between seizures. It is a medical emergency and needs immediate medical attention. Psypose 2mg Injection slows down electrical signals in the brain which cause seizures (fits). It can also help reduce symptoms such as confusion, uncontrollable jerking movements, loss of awareness, and fear or anxiety. It is given as an injection by a doctor or nurse. In Treatment of Short term anxiety Psypose 2mg Injection reduces the symptoms of excessive anxiety and worry that may arise in stressful conditions such as an exam or job interview. It can also reduce feelings of restlessness, tiredness, difficulty concentrating and feeling irritable. This will therefore help you go about your daily activities more easily and be more productive. Keep taking this medicine even if you feel well. Stopping suddenly can cause serious problems.In Treatment of Anxiety disorder
Side Effects
Side effects of Psypose Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Psypose Dizziness Sedation Injection site pain Fatigue Muscle weakness Drowsiness
How to use
How to use Psypose Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
How Psypose Injection works Psypose 2mg Injection is a benzodiazepine. It works by increasing the action of a chemical messenger (GABA) which suppresses the abnormal and excessive activity of the nerve cells in the brain.
Unsafe: Avoid consuming alcohol with Psypose 2mg Injection as it is deemed unsafe.
Psypose 2mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Psypose 2mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.Psypose 2mg Injection should be used for short periods and sleepiness of the baby should be watched. The withdrawal of Psypose 2mg Injection should be gradual.
Psypose 2mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Psypose 2mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Psypose 2mg Injection may be needed. Doctor consultation is advised.However, inform your doctor if you have any underlying kidney disease.
Psypose 2mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Psypose 2mg Injection may be needed. Doctor consultation is advised.Use of Psypose 2mg Injection is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Psypose 2mg Injection is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
SCO 325, 1st Floor, Sector 38-D, Chandigarh - 160036 Chandigarh, India
References
Stahl SM, editor. Lorazepam. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 367-71
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 819-20
Drugs.com. Lorazepam Pregnancy and Breastfeeding Warnings (25 Mar. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (20 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (25 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Top Selling Medicines
Top Selling Devices
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100
Download Now
